These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2903236)

  • 21. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors.
    Vizi ES; Harsing LG; Gaal J; Kapocsi J; Bernath S; Somogyi GT
    J Pharmacol Exp Ther; 1986 Aug; 238(2):701-6. PubMed ID: 2874217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alpha-adrenoceptor stimulation of isolated canine, ferret and guinea pig airways.
    Mukherjee A; Wasserman MA
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):333-9. PubMed ID: 2888935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium utilization in the vasoconstriction to enantiomers of SK&F 89748-A.
    Matthews WD; Macia RA; Beckeringh JJ; DeMarinis RM; de Jonge A; Thoolen MJ; Wilffert B; Timmermans PB; van Zwieten PA
    J Pharmacol Exp Ther; 1985 Feb; 232(2):330-6. PubMed ID: 2857195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SK&F 104078, a post-junctionally selective alpha 2-adrenoceptor antagonist in the human saphenous vein in vitro.
    Roberts SP; Kelly J; Cawthorne MA; Sennitt MV
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):327-32. PubMed ID: 1352382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of alpha adrenoceptors on vascular smooth muscle: electrophysiological differentiation in canine saphenous vein.
    Matthews WD; McCafferty GP; Grous M
    J Pharmacol Exp Ther; 1984 Nov; 231(2):355-60. PubMed ID: 6149307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrochemical and electrophysiological analysis of the effects of SK&F 104078 on prejunctional alpha 2-adrenoceptors.
    Bao JX; Gonon F; Stjärne L
    Eur J Pharmacol; 1991 Oct; 203(2):159-63. PubMed ID: 1686858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
    Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
    Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries.
    Medgett IC; Hicks PE; Langer SZ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):159-65. PubMed ID: 6149302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency- and train length-dependent variation in the roles of postjunctional alpha 1- and alpha 2-adrenoceptors for the field stimulation-induced neurogenic contraction of rat tail artery.
    Bao JX; Gonon F; Stjärne L
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):601-16. PubMed ID: 8103193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of pre- and postjunctional beta adrenoceptor-mediated effects in the canine saphenous vein at birth.
    Guimarães S; Moura D; Paiva MQ; Vaz-da-Silva MJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):990-5. PubMed ID: 8114015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in prejunctional adrenoceptor function in guinea pig and rat vas deferens after chronic ganglionic blockade.
    Sax RD; Westfall TC
    J Pharmacol Exp Ther; 1981 Oct; 219(1):21-6. PubMed ID: 6116794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of postjunctional alpha 1-adrenoceptors in mammalian aortae: subclassification based on chlorethylclonidine, WB 4101 and nifedipine.
    Oriowo MA; Ruffolo RR
    J Vasc Res; 1992; 29(1):33-40. PubMed ID: 1313316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
    Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity.
    Kenakin TP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):210-9. PubMed ID: 6109772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs.
    Olmez E; Ilhan M
    Arzneimittelforschung; 1992 Sep; 42(9):1095-7. PubMed ID: 1359895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological profile of the novel alpha-adrenoceptor antagonist KT-611 (naftopidil).
    Muramatsu I; Yamanaka K; Kigoshi S
    Jpn J Pharmacol; 1991 Mar; 55(3):391-8. PubMed ID: 1677438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.